Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

Plasma von Willebrand factor antigen levels in non-small cell lung cancer patients.

Martini F, Ferroni P, Guadagni F, Basili S, Spila A, D'Alessandro R, Mineo D, Laudisi A, Portarena I, Mariotti S, Ambrogi V, Mineo TC, Roselli M.

Anticancer Res. 2005 Jan-Feb;25(1B):403-7.

2.

Prognostic value of carcinoembryonic antigen and CYFRA21-1 in patients with pathological stage I non-small cell lung cancer.

Matsuoka K, Sumitomo S, Nakashima N, Nakajima D, Misaki N.

Eur J Cardiothorac Surg. 2007 Sep;32(3):435-9. Epub 2007 Jul 3.

PMID:
17611117
3.

Preoperative serum carcinoembryonic antigen level is a prognostic factor in women with early non-small-cell lung cancer.

Hsu WH, Huang CS, Hsu HS, Huang WJ, Lee HC, Huang BS, Huang MH.

Ann Thorac Surg. 2007 Feb;83(2):419-24.

PMID:
17257963
4.

Plasma levels of von Willebrand factor antigen in acute bronchitis and in a normal population.

Boldy DA, Short PE, Cowen P, Hill FG, Chambers DC, Ayres JG.

Respir Med. 1998 Mar;92(3):395-400.

5.

Serum vascular endothelial growth factor (VEGF) and bcl-2 levels in advanced stage non-small cell lung cancer.

Tas F, Duranyildiz D, Oguz H, Camlica H, Yasasever V, Topuz E.

Cancer Invest. 2006 Oct;24(6):576-80.

PMID:
16982461
6.

The prognostic value of carcinoembryonic antigen in T1N1M0 and T2N1M0 non-small cell carcinoma of the lung.

Fukai R, Sakao Y, Sakuraba M, Oh S, Shiomi K, Sonobe S, Saitoh Y, Miyamoto H.

Eur J Cardiothorac Surg. 2007 Sep;32(3):440-4. Epub 2007 Jul 23.

PMID:
17643308
7.

Abnormalities in circulating von Willebrand factor and survival in pulmonary hypertension.

Lopes AA, Maeda NY, Bydlowski SP.

Am J Med. 1998 Jul;105(1):21-6.

PMID:
9688017
8.

Familial clustering of factor VIII and von Willebrand factor levels.

Kamphuisen PW, Houwing-Duistermaat JJ, van Houwelingen HC, Eikenboom JC, Bertina RM, Rosendaal FR.

Thromb Haemost. 1998 Feb;79(2):323-7.

PMID:
9493584
9.

Pathologic stage I non-small cell lung cancer with high levels of preoperative serum carcinoembryonic antigen: clinicopathologic characteristics and prognosis.

Matsuguma H, Nakahara R, Igarashi S, Ishikawa Y, Suzuki H, Miyazawa N, Honjo S, Yokoi K.

J Thorac Cardiovasc Surg. 2008 Jan;135(1):44-9. doi: 10.1016/j.jtcvs.2007.09.032.

11.

Serum levels of IGF-I and IGFBP-3 in patients with lung cancer during chemotherapy.

Izycki T, Chyczewska E, Naumnik W, Ossolinska M.

Oncol Res. 2006;16(1):49-54.

PMID:
16783968
12.

Serum tenascin-C as a potential predictive marker of angiogenesis in non-small cell lung cancer.

Ishiwata T, Takahashi K, Shimanuki Y, Ohashi R, Cui R, Takahashi F, Shimizu K, Miura K, Fukuchi Y.

Anticancer Res. 2005 Jan-Feb;25(1B):489-95.

13.

von Willebrand factor and its propeptide: the influence of secretion and clearance on protein levels and the risk of venous thrombosis.

Nossent AY, VAN Marion V, VAN Tilburg NH, Rosendaal FR, Bertina RM, VAN Mourik JA, Eikenboom HC.

J Thromb Haemost. 2006 Dec;4(12):2556-62. Epub 2006 Oct 16.

14.

Serum Sialyl Lewis x and cytokeratin 19 fragment as predictive factors for recurrence in patients with stage I non-small cell lung cancer.

Mizuguchi S, Nishiyama N, Iwata T, Nishida T, Izumi N, Tsukioka T, Inoue K, Uenishi T, Wakasa K, Suehiro S.

Lung Cancer. 2007 Dec;58(3):369-75. Epub 2007 Aug 13.

PMID:
17697728
15.

An association between preoperative anemia and decreased survival in early-stage non-small-cell lung cancer patients treated with surgery alone.

Yovino S, Kwok Y, Krasna M, Bangalore M, Suntharalingam M.

Int J Radiat Oncol Biol Phys. 2005 Aug 1;62(5):1438-43.

PMID:
16029805
16.
17.

Pharmacokinetic studies on Wilfactin, a von Willebrand factor concentrate with a low factor VIII content treated with three virus-inactivation/removal methods.

Goudemand J, Scharrer I, Berntorp E, Lee CA, Borel-Derlon A, Stieltjes N, Caron C, Scherrmann JM, Bridey F, Tellier Z, Federici AB, Mannucci PM.

J Thromb Haemost. 2005 Oct;3(10):2219-27.

18.

Comparison of the pharmacokinetics of two von Willebrand factor concentrates [Biostate and AHF (High Purity)] in people with von Willebrand disorder. A randomised cross-over, multi-centre study.

Favaloro EJ, Lloyd J, Rowell J, Baker R, Rickard K, Kershaw G, Street A, Scarff K, Barrese G, Maher D, McLachlan AJ.

Thromb Haemost. 2007 Jun;97(6):922-30.

PMID:
17549293
19.

Circulating 25-hydroxyvitamin D levels predict survival in early-stage non-small-cell lung cancer patients.

Zhou W, Heist RS, Liu G, Asomaning K, Neuberg DS, Hollis BW, Wain JC, Lynch TJ, Giovannucci E, Su L, Christiani DC.

J Clin Oncol. 2007 Feb 10;25(5):479-85.

PMID:
17290055
20.

Preoperative C-reactive protein levels are associated with tumor size and lymphovascular invasion in resected non-small cell lung cancer.

Lee JG, Cho BC, Bae MK, Lee CY, Park IK, Kim DJ, Ahn SV, Chung KY.

Lung Cancer. 2009 Jan;63(1):106-10. doi: 10.1016/j.lungcan.2008.04.011. Epub 2008 Jun 2.

PMID:
18513823

Supplemental Content

Support Center